Viridian Therapeutics, Inc. VRDN Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s shares reserved for future issuance under stock plans?
- Viridian Therapeutics, Inc. (VRDN) reported shares reserved for future issuance under stock plans of 6.7M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Viridian Therapeutics, Inc.'s shares reserved for future issuance under stock plans increased by 196.8% year-over-year, from 2.3M to 6.7M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.